2023-11-012024-10-312024-10-31false09831147Elevate Physio Ltd2025-02-1786220falseiso4217:GBPxbrli:pure098311472023-11-01098311472024-10-31098311472023-11-012024-10-31098311472022-11-01098311472023-10-31098311472022-11-012023-10-3109831147bus:SmallEntities2023-11-012024-10-3109831147bus:AuditExempt-NoAccountantsReport2023-11-012024-10-3109831147bus:AbridgedAccounts2023-11-012024-10-3109831147bus:PrivateLimitedCompanyLtd2023-11-012024-10-3109831147core:WithinOneYear2024-10-3109831147core:AfterOneYear2024-10-3109831147core:WithinOneYear2023-10-3109831147core:AfterOneYear2023-10-3109831147core:ShareCapital2024-10-3109831147core:SharePremium2024-10-3109831147core:RevaluationReserve2024-10-3109831147core:OtherReservesSubtotal2024-10-3109831147core:RetainedEarningsAccumulatedLosses2024-10-3109831147core:ShareCapital2023-10-3109831147core:SharePremium2023-10-3109831147core:RevaluationReserve2023-10-3109831147core:OtherReservesSubtotal2023-10-3109831147core:RetainedEarningsAccumulatedLosses2023-10-3109831147core:LandBuildings2024-10-3109831147core:PlantMachinery2024-10-3109831147core:Vehicles2024-10-3109831147core:FurnitureFittings2024-10-3109831147core:OfficeEquipment2024-10-3109831147core:NetGoodwill2024-10-3109831147core:IntangibleAssetsOtherThanGoodwill2024-10-3109831147core:ListedExchangeTraded2024-10-3109831147core:UnlistedNon-exchangeTraded2024-10-3109831147core:LandBuildings2023-10-3109831147core:PlantMachinery2023-10-3109831147core:Vehicles2023-10-3109831147core:FurnitureFittings2023-10-3109831147core:OfficeEquipment2023-10-3109831147core:NetGoodwill2023-10-3109831147core:IntangibleAssetsOtherThanGoodwill2023-10-3109831147core:ListedExchangeTraded2023-10-3109831147core:UnlistedNon-exchangeTraded2023-10-3109831147core:LandBuildings2023-11-012024-10-3109831147core:PlantMachinery2023-11-012024-10-3109831147core:Vehicles2023-11-012024-10-3109831147core:FurnitureFittings2023-11-012024-10-3109831147core:OfficeEquipment2023-11-012024-10-3109831147core:NetGoodwill2023-11-012024-10-3109831147core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3109831147core:ListedExchangeTraded2023-11-012024-10-3109831147core:UnlistedNon-exchangeTraded2023-11-012024-10-3109831147core:MoreThanFiveYears2023-11-012024-10-3109831147core:Non-currentFinancialInstruments2024-10-3109831147core:Non-currentFinancialInstruments2023-10-3109831147dpl:CostSales2023-11-012024-10-3109831147dpl:DistributionCosts2023-11-012024-10-3109831147core:LandBuildings2023-11-012024-10-3109831147core:PlantMachinery2023-11-012024-10-3109831147core:Vehicles2023-11-012024-10-3109831147core:FurnitureFittings2023-11-012024-10-3109831147core:OfficeEquipment2023-11-012024-10-3109831147dpl:AdministrativeExpenses2023-11-012024-10-3109831147core:NetGoodwill2023-11-012024-10-3109831147core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3109831147dpl:GroupUndertakings2023-11-012024-10-3109831147dpl:ParticipatingInterests2023-11-012024-10-3109831147dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-012024-10-3109831147core:ListedExchangeTraded2023-11-012024-10-3109831147dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-012024-10-3109831147core:UnlistedNon-exchangeTraded2023-11-012024-10-3109831147dpl:CostSales2022-11-012023-10-3109831147dpl:DistributionCosts2022-11-012023-10-3109831147core:LandBuildings2022-11-012023-10-3109831147core:PlantMachinery2022-11-012023-10-3109831147core:Vehicles2022-11-012023-10-3109831147core:FurnitureFittings2022-11-012023-10-3109831147core:OfficeEquipment2022-11-012023-10-3109831147dpl:AdministrativeExpenses2022-11-012023-10-3109831147core:NetGoodwill2022-11-012023-10-3109831147core:IntangibleAssetsOtherThanGoodwill2022-11-012023-10-3109831147dpl:GroupUndertakings2022-11-012023-10-3109831147dpl:ParticipatingInterests2022-11-012023-10-3109831147dpl:GroupUndertakingscore:ListedExchangeTraded2022-11-012023-10-3109831147core:ListedExchangeTraded2022-11-012023-10-3109831147dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-11-012023-10-3109831147core:UnlistedNon-exchangeTraded2022-11-012023-10-3109831147core:NetGoodwill2024-10-3109831147core:IntangibleAssetsOtherThanGoodwill2024-10-3109831147core:LandBuildings2024-10-3109831147core:PlantMachinery2024-10-3109831147core:Vehicles2024-10-3109831147core:FurnitureFittings2024-10-3109831147core:OfficeEquipment2024-10-3109831147core:AfterOneYear2024-10-3109831147core:WithinOneYear2024-10-3109831147core:ListedExchangeTraded2024-10-3109831147core:UnlistedNon-exchangeTraded2024-10-3109831147core:ShareCapital2024-10-3109831147core:SharePremium2024-10-3109831147core:RevaluationReserve2024-10-3109831147core:OtherReservesSubtotal2024-10-3109831147core:RetainedEarningsAccumulatedLosses2024-10-3109831147core:NetGoodwill2023-10-3109831147core:IntangibleAssetsOtherThanGoodwill2023-10-3109831147core:LandBuildings2023-10-3109831147core:PlantMachinery2023-10-3109831147core:Vehicles2023-10-3109831147core:FurnitureFittings2023-10-3109831147core:OfficeEquipment2023-10-3109831147core:AfterOneYear2023-10-3109831147core:WithinOneYear2023-10-3109831147core:ListedExchangeTraded2023-10-3109831147core:UnlistedNon-exchangeTraded2023-10-3109831147core:ShareCapital2023-10-3109831147core:SharePremium2023-10-3109831147core:RevaluationReserve2023-10-3109831147core:OtherReservesSubtotal2023-10-3109831147core:RetainedEarningsAccumulatedLosses2023-10-3109831147core:NetGoodwill2022-11-0109831147core:IntangibleAssetsOtherThanGoodwill2022-11-0109831147core:LandBuildings2022-11-0109831147core:PlantMachinery2022-11-0109831147core:Vehicles2022-11-0109831147core:FurnitureFittings2022-11-0109831147core:OfficeEquipment2022-11-0109831147core:AfterOneYear2022-11-0109831147core:WithinOneYear2022-11-0109831147core:ListedExchangeTraded2022-11-0109831147core:UnlistedNon-exchangeTraded2022-11-0109831147core:ShareCapital2022-11-0109831147core:SharePremium2022-11-0109831147core:RevaluationReserve2022-11-0109831147core:OtherReservesSubtotal2022-11-0109831147core:RetainedEarningsAccumulatedLosses2022-11-0109831147core:AfterOneYear2023-11-012024-10-3109831147core:WithinOneYear2023-11-012024-10-3109831147core:Non-currentFinancialInstrumentscore:CostValuation2023-11-012024-10-3109831147core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-012024-10-3109831147core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-012024-10-3109831147core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-012024-10-3109831147core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-012024-10-3109831147core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-012024-10-3109831147core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-012024-10-3109831147core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-012024-10-3109831147core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-012024-10-3109831147core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3109831147core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3109831147core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3109831147core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3109831147core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3109831147core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3109831147core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3109831147core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3109831147core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3109831147core:Non-currentFinancialInstrumentscore:CostValuation2023-10-3109831147core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-3109831147core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-3109831147core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-3109831147core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-3109831147core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-3109831147core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-3109831147core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-3109831147core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-3109831147bus:Director12023-11-012024-10-31

Elevate Physio Ltd

Registered Number
09831147
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2024

Elevate Physio Ltd
Company Information
for the year from 1 November 2023 to 31 October 2024

Director

Simon John Baker

Registered Address

4 Old Station Way
Yeovil
BA20 1EL

Registered Number

09831147 (England and Wales)
Elevate Physio Ltd
Balance Sheet as at
31 October 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3701824
701824
Current assets
Debtors4156268
Cash at bank and on hand12,1076,362
12,2636,630
Creditors amounts falling due within one year5(8,980)(7,441)
Net current assets (liabilities)3,283(811)
Total assets less current liabilities3,98413
Net assets3,98413
Capital and reserves
Called up share capital11
Profit and loss account3,98312
Shareholders' funds3,98413
The financial statements were approved and authorised for issue by the Director on 17 February 2025, and are signed on its behalf by:
Simon John Baker
Director
Registered Company No. 09831147
Elevate Physio Ltd
Notes to the Financial Statements
for the year ended 31 October 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery15
Office Equipment15
2.Average number of employees

20242023
Average number of employees during the year00
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 November 233,425
At 31 October 243,425
Depreciation and impairment
At 01 November 232,601
Charge for year123
At 31 October 242,724
Net book value
At 31 October 24701
At 31 October 23824
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables156268
Total156268
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2024

2023

££
Taxation and social security5,6054,152
Other creditors1,8551,692
Accrued liabilities and deferred income1,5201,597
Total8,9807,441
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.